ADVI Health Acquires Partnership for Health Analytic Research (PHAR)

ADVI Health announce the acquisition of Partnership for Health Analytic Research (PHAR), a global health technology assessment (HTA) and health economics and outcomes research (HEOR) consultancy, known for providing high-impact, data-driven insights to some of the largest biopharmaceutical sponsors and clients.

Read also – Archer Secures PIPE As Part Of $230M In Capital Raised

This addition to ADVI’s Strategic Analytics, Value and Economics (SAVEs) team bolsters ADVI’s data analysis and value strategy capabilities with significant HEOR expertise, with the PHAR team bringing 20 years’ experience in primary and secondary real-world data research, patient registries, expert panels, and literature reviews.

Read also – [Funding News] Accession Risk Management Group Secures $1 Billion Incremental Debt Raise and Refinancing

“As the healthcare landscape continues to evolve, so do our clients’ needs. With decades of experience and deep-bench knowledge, PHAR brings a depth of expertise that complements our SAVEs and Market Access teams. I am excited to improve and expand our service offerings for our clients moving forward,” said Marc Samuels, CEO of ADVI Health.

The acquisition underscores ADVI Health’s mission and vision to be the go-to-market partner for life sciences innovators worldwide by helping our clients advance patient access, accelerate time to reimbursement, and achieve optimal business results by providing data-informed strategy and access solutions that create opportunity, generate evidence, optimize strategy, and fund growth. By integrating PHAR’s data analytics experts, most known for their implementation science, ADVI expands its work with the evidence behind clinical and retrospective value assessments.

Marc and Caitlin Sheetz, Head of SAVEs, welcome Dr. Michael Broder, founder of PHAR, Eunice Chang PhD, and the rest of the PHAR team. “Joining ADVI is an incredible opportunity for our team. We are looking forward to exploring new ways to generate impactful results—both for the clients we have had for so many years and for the new ones we will meet through our partnership with ADVI,” said Dr. Broder, PHAR CEO and Founder. “With so many novel therapeutics coming to market, it is more important than ever for life science companies to use real-world data to show the true value of their products. We believe joining ADVI will help us expand our research offerings to support brand launch, enable access to on-market products, and bolster life cycle performance.”

About ADVI Health

ADVI Health is the strategic consulting partner to the healthcare and life sciences ecosystem. A leading life sciences data and consulting services firm with offices in Austin, Chicago, San Francisco, and Washington, D.C., we solve complicated problems in healthcare with data-informed commercialization, market access, and policy expertise. From development and design to strategy and execution we succeed for clients across managed services, MedTech, pharma, and precision medicine, with insights, products, and services across the product lifecycle.

About PHAR (Partnership for Health Analytic Research)

PHAR, LLC provides consulting and research services to development, marketing, and health economics professionals in the life science industry. PHAR’s experienced clinicians, researchers, and methodologists help our clients satisfy internal and external customers by consistently delivering high-quality results.